THE NNP TRINITY

Program. Predict. Produce.

SHIFTBIO's integrated engine transforms cell-derived nanoparticles into a programmable, pharma-grade delivery platform, NNP.

PROGRAM

NSM Scaffold

We uncovered how proteins are selectively enriched in extracellular vesicles and identified a key sorting motif. NSM is our proprietary transmembrane domains that interact with all three major tetraspanins to drive efficient EV sorting.

A universal engineering scaffold that loads hundreds to thousands of therapeutic cargoes per NNP, with plug-and-play targeting for any organ.

NSM Scaffold

High-Density Loading

Engineered to load hundreds to thousands of therapeutic cargoes per NNP

Multi-Cargo Versatility

Unparalleled compatibility with both Proteins and RNA (ASO, siRNA, mRNA)

Plug-and-Play Modularity

Customizing targeting moieties for diverse organ specificity

NSM-Cargo
Variants

Structure
Modeling

Interface
Descriptors

ML Model
Prediction

In silico Structure-Activity Analysis

PREDICT

NNP Design AI™

Predict before you build.
Months, not years.

NSM operates through protein-protein interactions with tetraspanins. This means we can computationally model each Cargo-NSM construct, analyze its tetraspanin interface, and predict engineering success before a single experiment is run.

Standardized biodata across every construct powers a machine learning model that turns structural descriptors into actionable design decisions, dramatically reducing development risk and timeline.

PRODUCE

NNP Manufacturing™

Successfully industrialized.
At commercial scale.

Cell-derived nanoparticles have long promised biological advantage but resisted industrialization. SHIFTBIO solved this with a scalable manufacturing process that delivers GMP-grade NNPs with 20× yield improvement, >95% purity, and batch-to-batch consistency.

Cell
Bank

200L
Bioreactor

DSP
Purification

NNP
Product

Scaled for Commercial Production
SHIFTBIO has successfully industrialized NNP

200L

Bioreactor Ready

>95%

High Purity

20×

Yield Gain

Nat. Comm.

Published 2025

AI-DRIVEN ITERATIVE DESIGN

Program, Predict, Produce

A closed-loop cycle where AI predictions are experimentally validated and results refine next-generation designs.

01NNP Design

NSM scaffold + Cargo loading + Targeting moiety

02NNP Design AI™

In silico prediction before wet-lab

03Scalable Manufacturing

Scale-up + High Purity + Consistency

Validated results feed back to refine next-generation designs

THE NNP TRINITY

Program. Predict. Produce.

SHIFTBIO's integrated engine transforms cell-derived nanoparticles into a programmable, pharma-grade delivery platform, NNP.

PROGRAM

NSM Scaffold

We uncovered how proteins are enriched in extracellular vesicles and identified a key sorting motif. NSM is our proprietary transmembrane domains that interact with all three major tetraspanins to drive efficient EV sorting.

A universal engineering scaffold that loads hundreds to thousands of therapeutic cargoes per NNP, with plug-and-play targeting for any organ.

NSM Scaffold

High-Density Loading

Engineered to load hundreds to thousands of therapeutic cargoes per NNP

Multi-Cargo Versatility

Unparalleled compatibility with both Proteins and RNA (ASO, siRNA, mRNA)

Plug-and-Play Modularity

Customizing targeting moieties for diverse organ specificity

NSM-Cargo
Variants

Structure
Modeling

Interface
Descriptors

ML Model
Prediction

In silico Structure-Activity Analysis

PREDICT

NNP Design AI™

Predict before you build.
Months, not years.

NSM operates through protein-protein interactions with tetraspanins. This means we can computationally model each Cargo-NSM construct, analyze its tetraspanin interface, and predict engineering success before a single experiment is run.

Standardized biodata across every construct powers a machine learning model that turns structural descriptors into actionable design decisions, dramatically reducing development risk and timeline.

PRODUCE

NNP Manufacturing™

Successfully industrialized.
At commercial scale.

Cell-derived nanoparticles have long promised biological advantage but resisted industrialization. SHIFTBIO solved this with a scalable manufacturing process that delivers GMP-grade NNPs with 20× yield improvement, >95% purity, and batch-to-batch consistency.

Cell
Bank

200L
Bioreactor

DSP
Purification

NNP
Product

Scaled for Commercial Production
SHIFTBIO has successfully industrialized NNP

200L

Bioreactor Ready

>95%

High Purity

20×

Yield Gain

Nat. Comm.

Published 2025

AI-DRIVEN ITERATIVE DESIGN

Program, Predict, Produce

A closed-loop cycle where AI predictions are experimentally validated and results refine next-generation designs.

01NNP Design

NSM scaffold + Cargo loading + Targeting moiety

02NNP Design AI™

In silico prediction before wet-lab

03Scalable Manufacturing

Scale-up + High Purity + Consistency

Validated results feed back to refine next-generation designs